Opioid use among 12 115 patients with early inflammatory arthritides compared to general population.
To assess to which extend the worldwide opioid epidemic affects the Finnish early inflammatory arthritis (IA) patients. From the nationwide register maintained by the Social Insurance Institution of Finland we collected all incident adult patients with newly-onset seropositive and seronegative rheumatoid arthritis (RA+ and RA-) and undifferentiated arthritis (UA) between 2010-14. For each case, three general population (GP) controls were matched according to age, sex, and place of residence. Drug purchases between 2009-15 were evaluated one year before and after the index date (date of IA diagnosis), further dividing this time into 3-month periods. A total of 12 115 patients (66.8 % women) were identified. At least one opioid purchase was done by 23-27 % of the patients one year before and 15-20 % one year after the index date. Relative risk (RR) of opioid purchases compared to GP was highest during the last 3-month time period before the index date [RR 2.81 (95 % confidence interval (CI) 2.55-3.09), 3.06 (2.68-3.49), and 4.04 (3.51-4.65) for RA+, RA- and UA, respectively] but decreased after the index date (RR 1.38 (1.23-1.58), 1.91 (1.63-2.24), and 2.51 (2.15-2.93). Approximately 4 % of the patients were long-term users both before and after the diagnosis. During 2009-15 in Finland, opioid use peaked just before the diagnosis of IA but decreased rapidly after that suggesting effective disease-control especially in seropositive RA. Further, opioids were used to treat arthritis pain of incident RA and UA patients less often than previously reported from other countries.